Degradable Cisplatin-Releasing Core-Shell Nanogels from Zwitterionic Poly(β -Aminoester)-Graft-PEG for Cancer Chemotherapy

REFERENCES

• Akinc A., Anderson D. G., Lynn D. M., Langer R. Synthesis of poly(β -amino ester)s optimized for highly effective gene delivery. Bioconjugate Chem. 2003; 14: 979–988
   PubMed Web of Science ®Google Scholar
• Anderson D. G., Lynn D. M., Langer R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew. Chem. Int. Ed. 2003; 42: 3153–3158
   PubMed Web of Science ®Google Scholar
• Aronov O., Horowitz A. T., Gabizon A., Fuertes M. A., Perez J. M., Gibson D. Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues. Bioconjugate Chem. 2004; 15: 814–823
   PubMed Web of Science ®Google Scholar
• Avichechter D., Schechter B., Arnon R. Functional polymers in drug delivery: carrier-supported CDDP (cis-platin) complexes of polycarboxylates—effect on human ovarian carcinoma. React. Funct. Polym. 1998; 36: 59–69
   Web of Science ®Google Scholar
• Bogdanov A. A., Jr., Martin C., Bogdanova A. V., Brady T. J., Weissleder R. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: Synthesis and cytotoxic properties. Bioconjugate Chem. 1996; 7: 144–149
   PubMed Web of Science ®Google Scholar
• Cabral H., Nishiyama N., Okazaki S., Koyama H., Kataoka K. Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles. J. Control. Rel. 2005; 101: 223–232
   PubMed Web of Science ®Google Scholar
• Fuertes M. A., Alonso C., Perez J. M. Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem. Rev. 2003; 103: 645–662
   PubMed Web of Science ®Google Scholar
• Gaucher G., Dufresne M.-H., Sant V. P., Kang N., Maysinger D., Leroux J.-C. Block copolymer micelles: preparation, characterization and application in drug delivery. J. Control. Rel. 2005; 109: 169–188
   PubMed Web of Science ®Google Scholar
• Gianasi E., Wasil M., Evagarou E. G., Keddle A., Wilson G., Duncan D. HPMA copolymer platinates as novel antitumor agents: in vitro properties, pharmacokinetics and antitumor activity in vivo. Eur. J. Cancer 1999; 35: 994–1002
   PubMed Web of Science ®Google Scholar
• Gillies E. R., Frechet J. M. J. Dendrimers and dendritic polymers in drug delivery. Drug Discov. Today 2005; 10: 35–43
   PubMed Web of Science ®Google Scholar
• Hobbs S. K., Monsky W. L., Yuan F., Roberts W. G., Griffith L., Torchilin V. P., Jain R. K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA 1998; 95: 4607–4612
   PubMed Web of Science ®Google Scholar
• Kwon G. S. Polymeric micelles for delivery of poorly water-soluble compounds. Crit. Rev. Therap. Drug Carrier Syst. 2003; 20: 357–403
   PubMed Web of Science ®Google Scholar
• Lajer H., Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat. Rev. 1999; 25: 47–58
   PubMed Web of Science ®Google Scholar
• Lee C. M., Tanaka T., Murai T., Kondo M. K. J., Su W., Kitagawa T., Ito T., Matsuda H., Miyasaka M. Novel condroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently supress the local growth and liver metastasis of tumor cells in vivo. Cancer Res. 2002; 62: 4282–4288
   PubMed Web of Science ®Google Scholar
• Lin X., Zhang Q., Rice J. R., Stewart D. R., Nowotnik D. P., Howell S. B. Improved targeting of platinum chemotherapeutics: the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour models. Eur. J. Cancer 2004; 40: 291–297
   PubMed Web of Science ®Google Scholar
• Linuma H., Maruyama K., Okinaga K., Sasaki K., Sekine T., Ishida O., Ogiwara N., Johkura K., Yonemura Y. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. Int. J. Cancer 2002; 99: 130–137
   PubMed Web of Science ®Google Scholar
• Little S. R., Lynn D. M., Ge Q., Anderson D. G., Puram S. V., Chen J., Eisen H. N., Langer R. Poly-b-amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc. Natl. Acad. Sci. USA 2004; 101: 9534–9539
   PubMed Web of Science ®Google Scholar
• Little S. R., Lynn D. M., Puram S. V., Langer R. Formulation and characterization of poly (b-amino ester) microparticles for genetic vaccine delivery. J. Control. Rel. 2005; 107: 449–462
   PubMed Web of Science ®Google Scholar
• Maeda H., Fang J., Inutsuka T., Kitamoto Y. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int. Immunopharmacol. 2003; 3: 319–328
   PubMed Web of Science ®Google Scholar
• Malik N., Evagorou E. G., Duncan R. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 1999; 10: 767–776
   PubMed Web of Science ®Google Scholar
• McKeage M. J. New-generation platinum drugs in the treatment of cisplatin-resistant cancers. Expert Opin. Invest. Drugs 2005; 14: 1033–1046
   PubMed Web of Science ®Google Scholar
• Molineux G. Pegylation: engineering improved pharmaceuticals for enhanced therapy. Cancer Treat. Rev. 2002; 28: 13–16, (suppl)
   PubMed Web of Science ®Google Scholar
• Newman M. S., Colbern G. T., Working P. K., Engbers C., Amantea M. A. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long circulating, pegylated liposomes (SPI-077) in tumorbearing mice. Cancer Chemother. Pharmacol. 1999; 43: 1–7
   PubMed Web of Science ®Google Scholar
• Nishiyama N., Koizumi F., Okazaki S., Matsumura Y., Nishio K., Kataoka K. Differential gene expression profile between PC-14 cells treated with freecisplatin and cisplatin-incorporated polymeric micelles. Bioconjugate Chem. 2003a; 14: 449–457
   PubMed Web of Science ®Google Scholar
• Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., Nishio K., Matsumura Y., Kataoka K. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 2003b; 63: 8977–8983
   PubMed Web of Science ®Google Scholar
• Nishiyama N., Yokoyama M., Aoyagi T., Okano T., Sakurai Y., Kataoka K. Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum(II) and poly(ethylene glycol)-poly(aspartic acid) block copolymer in an aqueous medium. Langmuir 1999; 15: 377–383
   Web of Science ®Google Scholar
• Perez R. P. Cellular and molecular determinants of cisplatin resistance. Eur. J. Cancer 1998; 34: 1535–1542
   PubMed Web of Science ®Google Scholar
• Pinzani V., Bressolle F., Hang I. J., Galtier M., Blayac J. P., Balmes P. Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother. Pharmacol. 1994; 35: 1–9
   PubMed Web of Science ®Google Scholar
• Rademaker-Lakhai J. M., Terret C., Howell S. B., Baud C. M., de Boer R. F., Pluim D., Beijnen J. H., Schellens J. H. M., Droz J.-P. A phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors. Clin. Cancer Res. 2004; 10: 3386–3395
   PubMed Web of Science ®Google Scholar
• Rosenberg B., VanCamp L., Trosko J. E., Mansour V. H. Platinum compounds: a new class of potent antitumor agents. Nature 1969; 222: 385–386
   PubMed Web of Science ®Google Scholar
• Senter P. D., Kopecek J. Drug carriers in medicine and biology. Mol. Pharm. 2004; 1: 395–398
   PubMedGoogle Scholar
• Shenoy D., Little S., Langer R., Amiji M. Poly(ethylene oxide)-modified poly(b-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. Mol. Pharm. 2005; 2: 357–366
   PubMed Web of Science ®Google Scholar
• Song R., Jun Y. J., Kim J. I., Jin C., Sohn Y. S. Synthesis, characterization, and tumor selectivity of a polyphosphazene-platinum(II) conjugate. J. Control. Rel. 2005; 105: 142–150
   PubMed Web of Science ®Google Scholar
• Torchilin V. P. Recent advances with liposomes as pharmaceutical carriers. Nature Rev. Drug Discov. 2005; 4: 145–160
   PubMed Web of Science ®Google Scholar
• Unezaki S., Maruyama K., Hosoda J.-I., Nagae I., Koyanagi Y., Nakata M., Ishida O., Iwatsuru M., Tsuchiya S. Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int. J. Pharm. 1996; 144: 11–17
   Web of Science ®Google Scholar
• Vicent M. J., Duncan R. Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechn. 2006; 24: 39–47
   PubMed Web of Science ®Google Scholar
• Wong E., Giandomenico C. M. Current status of platinum-based antitumor drugs. Chem. Rev. 1999; 99: 2451–2466
   PubMed Web of Science ®Google Scholar
• Xu P., Li S.-Y., Li Q., Ren J., Van Kirk E. A., Murdoch W. J., Radosz M., Shen Y. Biodegradable cationic polyester as an efficient carrier for gene delivery to neonatal cardiomyocytes. Biotech. Bioeng. 2006a; 95: 893–903
   PubMed Web of Science ®Google Scholar
• Xu P., Van Kirk E. A., Li S.-Y., Murdoch W. J., Ren J., Hussain M. D., Radosz M., Shen Y. Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloi. Surf. B: Biointerf. 2006b; 48: 50–57
   PubMed Web of Science ®Google Scholar
• Xu P., Van Kirk E. A., Murdoch W. J., Zhan Y., Isaak D. D., Radosz M., Shen Y. Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles. Biomacromolecules 2006c; 7: 829–835
   PubMed Web of Science ®Google Scholar
• Yuan F., Dellian M., Fukumura D., Leuning M., Berk D. D., Torchilin V. P., Jain R. K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995; 55: 3752–3756
   PubMed Web of Science ®Google Scholar